News & Updates
Filter by Specialty:

Tislelizumab improves survival in advanced gastric/gastro-oesophageal junction adenocarcinoma
First-line treatment with tislelizumab plus chemotherapy for advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma yields better overall survival and an acceptable safety profile compared with chemotherapy plus placebo in patients with a programmed death-ligand 1 (PD-L1) tumour area positivity (TAP) score of ≥5 percent, a study has shown.
Tislelizumab improves survival in advanced gastric/gastro-oesophageal junction adenocarcinoma
04 Jun 2024
Legume intake reduces colorectal cancer risk
Eating legumes may help avert the development of colorectal cancer, according to a study that has found an inverse association between legume consumption and colorectal cancer risk.
Legume intake reduces colorectal cancer risk
03 Jun 2024
Tobacco smoke exposure early in life ups paediatric IBD risk
A Scandinavian population-based birth cohort study reveals that children who were exposed to tobacco smoke during their early childhood have an increased risk of developing inflammatory bowel disease (IBD) later in life.
Tobacco smoke exposure early in life ups paediatric IBD risk
03 Jun 2024
Mum’s infection during pregnancy may raise newborn’s risk of IBD
Exposure to any infection during early pregnancy or to a gastrointestinal infection during late pregnancy contributes to the increased likelihood of inflammatory bowel disease (IBD) development, especially Crohn’s disease, in the offspring, according to a study.